(Q46122207)

English

Changes in the natural history of nonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990.

scientific article published in May 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16604529

Changes in the natural history of nonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16604529

non-small-cell lung carcinoma

1 reference

based on heuristic

inferred from title

author name string

Heather A Wakelee

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16604529

Patricia Bernardo

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16604529

David H Johnson

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16604529

Joan H Schiller

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16604529

language of work or name

0 references

publication date

1 May 2006

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16604529

number of pages

10

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16604529

106

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16604529

10

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16604529

2208-2217

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16604529

Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

21 January 2018

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of acivicin versus etoposide-cisplatin in non-small cell lung cancer. An Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of gallium nitrate, amonafide and teniposide in metastatic non-small cell lung cancer. An Eastern Cooperative Oncology Group study (E2588)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Trastuzumab in the treatment of advanced non-small-cell lung cancer: is there a role? Focus on Eastern Cooperative Oncology Group study 2598.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Polychemotherapy in advanced non small cell lung cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Sex differences in survival in non-small cell lung cancer patients 1974-1998

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Lung cancer in US women: a contemporary epidemic

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolution of surgical outcomes for nonsmall cell lung cancer: time trends in 1465 consecutive patients undergoing complete resection.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Time trends in lung cancer incidence by histology in South Australia: likely causes and public health implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

The changing epidemiology of lung cancer in Europe

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors affecting long term survival following resection for lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival predictors in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Erlotinib in previously treated non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel versus docetaxel plus cisplatin as front-line treatment of patients with advanced non-small-cell lung cancer: a randomized, multicenter phase III trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine versus gemcitabine/carboplatin in advanced non-small cell lung cancer: preliminary findings in a phase III trial of the Swedish Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefits of Adding a Drug to a Single-Agent or a 2-Agent Chemotherapy Regimen in Advanced Non–Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21869

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.21869

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16604529

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16604529

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46122207&oldid=1768071943"